A 10-year Retrospective Review of Botulinum Toxin Injections and Surgical Management of Sialorrhea

• Published in: Curēus (Palo Alto, CA) Vol. 12; no. 5; p. e7916
• Main Authors: Weitzman, Rachel E, Kawai, Kosuke, Nuss, Roger, Hughes, Amy
• Format: Journal Article
• Language: English
• Published: Palo Alto Cureus Inc 01.05.2020; Cureus
• Subjects: Age; Antibiotics; Botulinum toxin; Caregivers; Cerebral palsy; Intervention; Ostomy; Otolaryngology; Patients; Pediatrics; Surgery
• ISSN: 2168-8184; 2168-8184
• DOI: 10.7759/cureus.7916

BackgroundSialorrhea is a common comorbidity among children with neurologic disorders. Botulinum toxin injections and surgical procedures are recommended for the management of pathological sialorrhea in patients who fail conservative management or with concerns for salivary aspiration. The following review evaluates outcomes following botulinum toxin injections and surgical interventions for sialorrhea over a 10-year period with a focus on treatment options and outcomes for patients with anterior and posterior drooling.MethodsThe study included all patients less than 25 years of age who underwent a procedure for drooling (Current Procedural Terminology (CPT) codes 42440, 42450, 42509, 42510, 64611 matched with the International Classification of Diseases (ICD)-9 and ICD-10 codes 527.7 and K11.7) from January 1, 2006 to December 31, 2015. A chart review collected demographics, drooling medication use, and type of drooling (anterior, posterior, both). Outcome variables included pre- and post-procedure number of bibs, parent-reported outcomes, post-intervention drooling medication requirement, post-procedure length of stay, and complications.ResultsSeventy-one patients were included in our analysis, with 88 total procedures performed. The average age at first intervention was 8.9 years; 43 patients were male and 40 patients had cerebral palsy. Thirty-one patients experienced posterior drooling or anterior/posterior drooling. These patients were more likely to undergo surgery as the first invasive intervention. The most commonly performed interventions were botulinum toxin injections (28 patients, 39%) and sublingual gland excision (SLGE) with submandibular duct ligation (SMDL) (36 patients, 51%). Improvement following injections was noted in 56% of patients versus 73% of patients following any surgical intervention.ConclusionManagement of drooling is complex with 18 different procedures performed over 10 years. Surgical interventions, specifically SLGE with SMDL and submandibular gland excision (SMGE), result in substantial improvement; these are commonly performed as the first intervention in patients with posterior drooling. By reviewing our experience, we hope to guide management decisions and help manage patient and caregiver expectations.